HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazunori Toyoda Selected Research

Nicardipine (Dagan)

10/2022Early Hyperchloremia is Independently Associated with Death or Disability in Patients with Intracerebral Hemorrhage.
1/2022Temporal Trajectory of Systolic Blood Pressure and Outcomes in Acute Intracerebral Hemorrhage: ATACH-2 Trial Cohort.
1/2022Controlling blood pressure soon after intracerebral hemorrhage: The SAMURAI-ICH Study and its successors.
1/2022Intensive blood pressure lowering with nicardipine and outcomes after intracerebral hemorrhage: An individual participant data systematic review.
10/2020Systolic Blood Pressure Reduction and Acute Kidney Injury in Intracerebral Hemorrhage.
1/2018Early Achievement of Blood Pressure Lowering and Hematoma Growth in Acute Intracerebral Hemorrhage: Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement-Intracerebral Hemorrhage Study.
1/2016Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage.
11/2014Intravenous nicardipine dosing for blood pressure lowering in acute intracerebral hemorrhage: the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-Intracerebral Hemorrhage study.
12/2012Systolic blood pressure lowering to 160 mmHg or less using nicardipine in acute intracerebral hemorrhage: a prospective, multicenter, observational study (the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-Intracerebral Hemorrhage study).
1/2012[Medical therapy for intracranial hemorrhage: update blood pressure management for prevention and acute treatment].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazunori Toyoda Research Topics

Disease

173Stroke (Strokes)
10/2022 - 01/2004
105Ischemic Stroke
07/2022 - 05/2003
49Hemorrhage
10/2022 - 09/2004
44Atrial Fibrillation
07/2022 - 01/2009
42Cerebral Hemorrhage
10/2022 - 11/2004
16Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2022 - 01/2004
16Embolism (Embolus)
01/2022 - 07/2004
16Infarction (Infarctions)
01/2022 - 01/2004
15Hypertension (High Blood Pressure)
01/2021 - 01/2004
14Hematoma
10/2022 - 05/2003
14Transient Ischemic Attack
01/2022 - 08/2015
14Embolic Stroke
01/2022 - 02/2014
7Atherosclerosis
02/2021 - 07/2007
7Thrombosis (Thrombus)
07/2018 - 01/2002
6Hemorrhagic Stroke
01/2022 - 06/2008
6Body Weight (Weight, Body)
01/2022 - 11/2014
6Myocardial Infarction
10/2021 - 01/2017
5Pathologic Constriction (Stenosis)
07/2022 - 01/2006
5COVID-19
07/2022 - 01/2020
5Cerebral Infarction
01/2022 - 06/2016
4Thrombocytopenia (Thrombopenia)
01/2022 - 01/2008
4Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2022 - 07/2010
4Infections
01/2020 - 01/2015
4Diabetes Mellitus
04/2018 - 01/2006
3Hyperglycemia
04/2022 - 11/2009
3Epilepsy (Aura)
01/2021 - 03/2014
3Cardiovascular Diseases (Cardiovascular Disease)
12/2020 - 06/2008
3Venous Thrombosis (Deep-Vein Thrombosis)
01/2019 - 04/2012
3Aortic Dissection
08/2018 - 01/2015
3Heart Failure
01/2018 - 11/2009
3Carotid Artery Diseases
01/2018 - 07/2007
3Paresis (Hemiparesis)
08/2016 - 09/2005
3Ischemia
01/2016 - 02/2011
3Thromboembolism
12/2015 - 01/2012
2Neoplasms (Cancer)
05/2022 - 01/2022
2Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
02/2022 - 01/2004
2Albuminuria
01/2022 - 02/2009
2Peripheral Arterial Disease
10/2021 - 01/2020
2Aneurysm (Aneurysms)
08/2021 - 05/2005
2Chronic Renal Insufficiency
10/2020 - 08/2014
2Aortic Aneurysm (Aneurysm, Aortic)
01/2020 - 09/2014
2Venous Thromboembolism
01/2020 - 01/2019
2Atrophy
01/2019 - 01/2006
2Moyamoya Disease (Moya-Moya Disease)
01/2019 - 05/2014
2Carotid Stenosis (Carotid Artery Stenosis)
01/2019 - 07/2004
2Brain Infarction
01/2019 - 05/2003

Drug/Important Bio-Agent (IBA)

53AnticoagulantsIBA
07/2022 - 05/2003
47Tissue Plasminogen Activator (Alteplase)FDA Link
03/2022 - 01/2009
24Warfarin (Coumadin)FDA LinkGeneric
01/2022 - 06/2008
23Antihypertensive Agents (Antihypertensives)IBA
10/2022 - 11/2003
14RivaroxabanIBA
01/2022 - 01/2013
13Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
07/2022 - 01/2009
13Clopidogrel (Plavix)FDA Link
07/2022 - 02/2015
11Vitamin KFDA Link
01/2022 - 04/2012
10Nicardipine (Dagan)FDA LinkGeneric
10/2022 - 01/2012
10fibrin fragment D (D-dimer)IBA
05/2022 - 01/2010
9DabigatranFDA Link
01/2022 - 04/2012
9Biomarkers (Surrogate Marker)IBA
05/2021 - 01/2015
8CreatinineIBA
01/2022 - 01/2006
8Heparin (Liquaemin)FDA LinkGeneric
01/2022 - 01/2008
8Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2020 - 04/2010
7Cilostazol (Pletal)FDA LinkGeneric
07/2022 - 02/2015
7Indicators and Reagents (Reagents)IBA
01/2021 - 06/2004
7Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2021 - 06/2008
6Fibrinolytic Agents (Antithrombotic Agents)IBA
01/2022 - 06/2008
5Hemoglobins (Hemoglobin)IBA
07/2021 - 01/2006
5Prasugrel HydrochlorideFDA Link
02/2021 - 04/2018
42'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
07/2022 - 02/2015
4Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2008
4Blood Glucose (Blood Sugar)IBA
12/2018 - 01/2009
4apixabanIBA
10/2018 - 01/2016
3Glucose (Dextrose)FDA LinkGeneric
04/2022 - 04/2013
3Pharmaceutical PreparationsIBA
02/2022 - 07/2013
3recombinant FVIIa (rFVIIa)FDA Link
01/2022 - 01/2021
3ThrombinFDA Link
01/2022 - 11/2020
3LipidsIBA
10/2021 - 01/2012
3Factor Xa InhibitorsIBA
01/2021 - 04/2012
3Hemostatics (Antihemorrhagics)IBA
01/2021 - 01/2016
3Pravastatin (Pravachol)FDA LinkGeneric
01/2019 - 03/2017
34- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA
08/2016 - 01/2012
2FibrinIBA
05/2022 - 01/2018
2Cytochrome P-450 CYP2C19IBA
03/2022 - 01/2019
2Factor VIIa (Activated Factor VII)IBA
01/2022 - 01/2021
2Brain Natriuretic Peptide (Natrecor)FDA Link
08/2021 - 05/2014
2Biological ProductsIBA
01/2021 - 01/2008
2CalciumIBA
01/2021 - 07/2013
2Tranexamic Acid (AMCA)FDA Link
01/2021 - 01/2021
2CollagenIBA
03/2019 - 02/2016
2idarucizumabIBA
10/2018 - 09/2018

Therapy/Procedure

104Therapeutics
07/2022 - 05/2003
26Thrombectomy
07/2022 - 01/2014
14Secondary Prevention
10/2021 - 01/2009
6Carotid Endarterectomy
01/2020 - 10/2005
6Renal Dialysis (Hemodialysis)
03/2018 - 01/2004
5Thrombolytic Therapy
04/2016 - 01/2002
4Drug Therapy (Chemotherapy)
01/2016 - 01/2009
3Catheter Ablation
01/2022 - 12/2019
3Stents
01/2021 - 06/2015
3Aftercare (After-Treatment)
01/2019 - 01/2013
3Treatment Delay
08/2016 - 11/2014